Azithromycin for Treatment of COVID-19

Long, B.; Gottlieb, M.

Long, B.; Gottlieb, M..

American Family Physician ; 105(3):233A-233B, 2022.

Article in English | EMBASE | ID: covidwho-2269593

Keywords

coronavirus disease 2019, drug megadose, health care cost, heart arrhythmia/si [Side Effect], hospital admission, hospitalization, human, length of stay, low drug dose, mortality, polymerase chain reaction, randomized controlled trial (topic), short survey, vaccination, vaccine hesitancy, azithromycin/ae [Adverse Drug Reaction], azithromycin/cm [Drug Comparison], azithromycin/iv [Intravenous Drug Administration], azithromycin/po [Oral Drug Administration]

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Language: English Journal: American Family Physician Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Language: English Journal: American Family Physician Year: 2022 Document Type: Article